I

Inotrem

35 employees

Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2013

Funding rounds raised

Total raised

$43M

from 9 investors over 9 rounds

I

Inotrem raised undisclosed on January 9, 2023

Investors: Crohn's & Colitis Foundation of America

I

Inotrem raised $15M on February 11, 2020

Investors: Kreos Capital

I

Inotrem raised $43M on September 12, 2019

Investors: Sofinnova Partners, Morningside Venture Capital 晨兴资本, The Invus Group and Andera Partners

I

Inotrem raised $25M on March 17, 2014

Investors: Sofinnova Partners, Andera Partners and BioMedPartners

FAQ